Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Sanarus Technologies Stories

2014-03-18 23:01:37

Sanarus Technologies announces the recent appointment of Lee Story as Sanarus’ President and member of the Board of Directors, and the appointment of Jim Plewa to Board of Directors. Pleasanton, CA (PRWEB) March 18, 2014 Sanarus Technologies, today announced the recent appointment of Lee Story as Sanarus’ President and member of the Board of Directors. Mr. Story brings more than 20 years of expertise to his new role having previously served as a former president, COO, CIO/CTO, and...

2014-02-06 23:01:15

Sanarus Technologies is pleased to announce the signing of a co-development agreement with The Centre for Surgical Invention and Innovation (CSii), creators of the new Image Guided Automatic Robotic (IGAR) system IGAR-Breast. Pleasanton, California (PRWEB) February 06, 2014 Sanarus Technologies is pleased to announce the signing of a co-development agreement with The Centre for Surgical Invention and Innovation (CSii), creators of the new Image Guided Automatic Robotic (IGAR) system...

2013-11-08 12:23:38

SANTA MONICA, Calif., CLEVELAND and CAESAREA, Israel, Nov. 8, 2013 /PRNewswire/ -- IceCure Medical Ltd. (TASE: ICCM) announced today that the John Wayne Cancer Institute (JWCI) at Saint John's Health Center in Santa Monica, CA, treated its first breast cancer patient using the IceSense3 Cryoablation System in a pilot study evaluating immune responses in patients with operable breast cancer. In this pilot study, patients undergo cryoablation of their breast cancer before surgery and...

2013-10-01 12:30:14

Lung cancer is by far the leading cause of cancer death among both men and women. Successful entrance into this market may significantly increase the company's business potential CAESAREA, Israel and CLEVELAND, Oct. 1, 2013 /PRNewswire/ -- IceCure Medical Ltd. (TASE: ICCM) announced today that it received its first order for cryoablation systems to be used in a clinical study for treatment of lung cancer tumors. The study will take place at the Kameda Medical Center in...

2013-05-07 16:30:02

Dr. Fukuma, a Pioneer in Non-Surgical Cryoablation Treatment of Breast Cancer Tumors Presented Results of Clinical Studies At The 2013 Conference of The American Society of Breast Surgeons (ASBrS) CHICAGO, May 7, 2013 /PRNewswire/ -- Dr. Eisuke Fukuma has treated 58 breast cancer patients with cryoablation over the last 6 years under a research protocol at Kameda Medical Center in Japan. As of today, none of the patients have had a tumor reoccur or distant metastases. By this...

2012-06-04 06:26:50

CAESAREA, Israel and CLEVELAND, June 4, 2012 /PRNewswire/ -- IceCure Medical Ltd. announced the first four breast cancer patients treated with the IceSense3(TM) Cryoablation Procedure in Japan. The IceSense3 System was used to treat small breast cancer tumors in a minimally invasive procedure using ultrasound guidance and local anesthesia. These patients were the first four enrolled in a clinical trial of 30 small, early stage breast cancer patients at Kameda Medical Center in Kamogawa City,...

2012-04-19 06:27:16

CINCINNATI, April 19, 2012 /PRNewswire/ -- Devicor® Medical Products, Inc. (Devicor), announced today the commercial launch of the Mammotome® elite Biopsy System, the only tetherless single insertion, multiple sample, vacuum-assisted biopsy (VAB) device featuring proprietary TruVac(TM) vacuum technology. Unlike competing devices that rely on automated syringes, elite provides a vacuum that achieves nearly the same suction power of the traditional Mammotome® VAB system, enabling...

2012-03-12 13:31:00

CINCINNATI, Ohio, March 12, 2012 /PRNewswire/ -- Devicor® Medical Products, Inc. (Devicor), announced today it has signed a distribution agreement with Carbon Medical Technologies, Inc. Under the agreement, Devicor, the parent company of Mammotome®, will have exclusive rights to market a new beta-glucan tissue marker developed by Carbon Medical Technologies. Financial terms of the agreement were not disclosed. The new marker will be used in breast biopsies to mark...

2008-12-05 13:16:00

CHICAGO, Dec. 5 /PRNewswire/ -- Early clinical experience with the FDA cleared Visica 2(TM) Treatment System from Sanarus Medical confirms the effectiveness of ultrasound guided cryoablation to completely eradicate small, unifocal Invasive Ductal Breast Cancer (IDC). Initial data from this multi-center study was presented at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), November 29 - December 5, 2008. The study, "New Findings on...

2008-12-02 05:00:00

IRVINE, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: ENDO), an innovative medical device company focused on the development of minimally invasive technologies used by urologists and interventional radiologists for tissue and tumor ablation, announced today that physicians from leading medical institutions including Mayo Clinic, Memorial Sloan-Kettering Cancer Center and the University of Wisconsin School of Medicine, among others, will present a total of 38 scientific...